Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertensive renal damage.

M R Weir, M K Hise

    Cardiovascular Clinics
    |January 1, 1991
    PubMed
    Summary
    This summary is machine-generated.

    Controlling systemic blood pressure is key for quality of life and preventing kidney damage. Improved therapies are needed for hypertensive black patients to prevent renal dysfunction and nephrosclerosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
    Same author

    Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).

    Journal of human hypertension·2012
    Same author

    Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
    Same author

    Can the early elimination of calcineurin inhibitors result in clinical benefits?

    Transplantation proceedings·2010
    Same author

    How early should blood pressure control be achieved for optimal cardiovascular outcomes?

    Journal of human hypertension·2010
    Same author

    Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

    Journal of human hypertension·2010
    Same journal

    Echo-Doppler in valvular heart disease.

    Cardiovascular clinics·1993
    Same journal

    Arrhythmias in valvular heart disease.

    Cardiovascular clinics·1993
    Same journal

    The electrocardiogram in valvular heart disease.

    Cardiovascular clinics·1993
    Same journal

    Acute rheumatic fever.

    Cardiovascular clinics·1993
    Same journal

    Valvuloplasty.

    Cardiovascular clinics·1993
    Same journal

    Immediate postoperative management.

    Cardiovascular clinics·1993
    See all related articles

    Area of Science:

    • Nephrology
    • Cardiovascular Medicine
    • Pharmacology

    Background:

    • Hypertension management requires simple, affordable, and nontoxic therapies.
    • Newer pharmacologic agents offer potential for preventing renal dysfunction but may have limited accessibility.
    • Lowering blood pressure effectively reduces target organ damage, but specific challenges exist in hypertensive black populations.

    Purpose of the Study:

    • To emphasize the importance of controlling systemic blood pressure for an adequate quality of life.
    • To highlight the need for improved therapies to prevent renal dysfunction in hypertensive black patients.
    • To explore a more physiologic approach to blood pressure control that conserves kidney perfusion.

    Main Methods:

    • Review of current nonpharmacologic and pharmacologic therapies for hypertension.

    Related Experiment Videos

  • Analysis of the impact of traditional and newer agents on renal function.
  • Consideration of cost-effectiveness and accessibility of treatments for diverse populations.

    • Main Results:

    • Lowering blood pressure by any method has historically reduced target organ damage.
    • Hypertensive black patients present a critical need for therapies that specifically prevent renal dysfunction.
    • A physiologic approach may delay nephrosclerosis by preserving kidney perfusion.

    Conclusions:

    • A combination of judicious traditional therapies and newer approaches offers the best strategy for blood pressure control and renal protection.
    • Addressing the unique needs of hypertensive black patients is crucial for preventing renal dysfunction.
    • Enhanced patient awareness, education, and support are vital for ensuring treatment compliance in this largely asymptomatic disease.